Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies

Gustave Roussy, Cancer Campus, Grand Paris141 enrolled

Overview

The aim of the study is to do a descriptive analysis of the cutaneous toxicity observed in patients treated using targeted therapies in order to have a better understanding of the skin pathophysiology.

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Enrollment

141

Conditions

Cancer

Interventions

BiopsyPROCEDURE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with cancer beginning a targeted therapy * Patients able to follow the protocol * Age \>/= 18 years old * Signed inform consent Exclusion Criteria: * Patient unable to follow the protocol, having a non cooperative behavior or unable to come to follow up visits or unable to complete the study * Pregnant or breastfeeding woman

Locations (1)

Gustave Roussy Cancer Campus Grand Paris

Villejuif, Val de Marne, France

Outcomes

Primary Outcomes

Number of clinical secondary effects bind to targeted therapies

Dermatological exam including questionnaire, clinical examination and photographies

Time frame: Every 28 days up to 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.